Browsing by Author Anjomani-Virmouni, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 15 of 15
Issue DateTitleAuthor(s)
2016Analysis of alternative lengthening of telomere markers in BRCA1 defective cellsKargaran, PK; Yasaei, H; Anjomani-Virmouni, S; Mangiapane, G; Slijepcevic, P
14-Nov-2019Elucidation of the metabolic signature of Friedreich’s ataxiaAnjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Perry, N; Tripp, A; Agliano, A; Al-Mahdawi, S; Pook, M
6-Feb-2024Emerging antioxidant therapies in Friedreich's ataxiaEdzeamey, FJ; Ramchunder, Z; Pourzand, C; Anjomani-Virmouni, S
2024Galleria mellonella as a drug discovery model for oxidative stress in Friedreich’s ataxia (FRDA).Edzeamey, FJ; Ramchunder, Z; McCarthy, R; Anjomani-Virmouni, S
2014Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell modelsSandi, C; Sandi, M; Jassal, H; Ezzatizadeh, V; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA
14-Nov-2019Genotype and Phenotype Characterisation of an Enhanced Friedreich Ataxia GAA Repeat Expansion Mouse Model Fxn_null::YG8s(GAA)>800Anjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Kleine, P; Oggianu, C; Hannana, T; Al-Mahdawi, S; Pook, M
2015Genotype and phenotype characterisation of enhanced Friedreich’s ataxia GAA repeat expansion mouse modelsAnjomani Virmouni, S; Sandi, C; Ezzatizadeh, V; Sandi, M; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S
5-Jun-2020HMTase Inhibitors as a Potential Epigenetic-based Therapeutic Approach for Friedreich’s AtaxiaSherzai, M; Valle, A; Perry, N; Kalef-Ezra, E; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S
1-May-2015Identification of telomere dysfunction in Friedreich ataxiaAnjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Slijepcevic, P; Pook, M
10-Jun-2015Identification of telomere dysfunction in Friedreich ataxia.Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M
2014MutLα heterodimers modify the molecular phenotype of Friedreich ataxiaEzzatizadeh, V; Sandi, C; Sandi, M; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA
2019Near Real-time Stratification of PIK3CA Mutant Breast Cancers Using the iKnifeKoundouros, N; Tripp, A; Karali, E; Valle, A; Inglese, P; Anjomani-Virmouni, S; Elder, G; van Weverwijk, A; Filipe-Soares, R; Isacke, C; Nicholson, J; Glen, RC; Takats, Z; Poulogiannis, G
16-Mar-2017PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-NitrosylationGupta, A; Anjomani-Virmouni, S; Koundouros, N; Dimitriadi, M; Choo-Wing, R; Valle, A; Zheng, Y; Chiu, YH; Agnihotri, S; Zadeh, G; Asara, JM; Anastasiou, D; Arends, MJ; Cantley, LC; Poulogiannis, G
19-May-2017PARK2 loss promotes cancer progression via redox-mediated inactivation of PTENGupta, A; Anjomani-Virmouni, S; Koundouros, N; Poulogiannis, G
1-Nov-2016Proteomics profiling of interactome dynamics by colocalisation analysis (COLA)Mardakheh, FK; Sailem, HZ; Kümper, S; Tape, CJ; McCully, RR; Paul, A; Anjomani-Virmouni, S; Jørgensen, C; Poulogiannis, G; Marshall, CJ; Bakal, C